1. Home
  2. ARVN vs SCHL Comparison

ARVN vs SCHL Comparison

Compare ARVN & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

SELL

Current Price

$6.82

Market Cap

600.2M

Sector

Health Care

ML Signal

SELL

Logo Scholastic Corporation

SCHL

Scholastic Corporation

SELL

Current Price

$38.94

Market Cap

672.6M

ML Signal

SELL

Company Overview

Basic Information
Metric
ARVN
SCHL
Founded
2015
1920
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Books
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
600.2M
672.6M
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
ARVN
SCHL
Price
$6.82
$38.94
Analyst Decision
Buy
Analyst Count
16
0
Target Price
★ $13.93
N/A
AVG Volume (30 Days)
★ 772.6K
520.9K
Earning Date
11-04-2026
09-24-2026
Dividend Yield
N/A
★ 2.55%
EPS Growth
58.84
★ 3442.86
EPS
★ 1.70
N/A
Revenue
$262,600,000.00
★ $1,487,100,000.00
Revenue This Year
$12.76
$2.14
Revenue Next Year
N/A
$3.42
P/E Ratio
$4.04
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$6.80
$26.38
52 Week High
$14.22
$48.07

Technical Indicators

Market Signals
Indicator
ARVN
SCHL
Relative Strength Index (RSI) 28.59 60.42
Support Level N/A $37.84
Resistance Level $8.52 $39.96
Average True Range (ATR) 0.30 1.63
MACD -0.03 0.61
Stochastic Oscillator 8.61 87.31

Price Performance

Historical Comparison
ARVN
SCHL

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About SCHL Scholastic Corporation

Scholastic Corp is a publisher and distributor of children's books, a provider of print and digital instructional materials for grades pre-kindergarten (pre-K) to grade 12 and a producer of entertaining literary and educational children's media. The company creates quality print, digital and audio books, learning materials and programs, classroom magazines and other products that, in combination, offer children, families and educators engaging and comprehensive solutions to support children's learning and reading both at home and at school. It categorizes its businesses into four reportable segments: Children's Book Publishing and Distribution; Education; Entertainment; and International. It derives the majority of revenue from Children's Book Publishing and Distribution segment.

Share on Social Networks: